Literature DB >> 10928958

Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.

A Sachinidis1, C Seul, I Gouni-Berthold, S Seewald, Y Ko, H Vetter, J Fingerle, J Hoppe.   

Abstract

The second messenger cyclic AMP regulates diverse biological processes such as cell morphology and cell growth. We examined the role of the second messenger cyclic AMP on rat aortic vascular smooth muscle cell (VSMC) morphology and the intracellular transduction pathway mediated by platelet-derived growth factor beta-receptor (PDGF-Rbeta). The effect of PDGF-BB on VSMCs growth was assessed by [(3)H]-thymidine incorporation. Tyrosine phosphorylation of PDGF-Rbeta, PLC-gamma1, ERK1 and ERK2, p125(FAK) and paxillin as well as Sm alpha-actin was examined by the chemiluminescence Western blotting method. Actin mRNA level was quantitated by Northern blotting. Visualization of Sm alpha-actin filaments, paxillin and PDGF-Rbeta was performed by immunfluorescence microscopy. Cholera toxin (CTX; 10 nM) treatment lead to a large and sustained increase in the cyclic AMP concentration after 2 h which correlated with change of VSMC morphology including complete disruption of the Sm alpha-actin filament array and loss of focal adhesions. Treatment of VSMCs with CTX did not influence tyrosine phosphorylation of p125(FAK) and paxillin but decreased the content of a Sm alpha-actin protein. Maximal decrease of 70% was observed after 24 h of treatment. CTX also caused a 90% decrease of the actin mRNA level. CTX treatment completely abolished PDGF-BB stimulated DNA-synthesis although PDGF-Rbeta level and subcellular distribution and translocation was not altered. Furthermore CTX attenuated the PDGF-BB-induced tyrosine phosphorylation of the PDGF-Rbeta, PI 3'-K, PLC-gamma1 and ERK1/2 indicating an action of cyclic AMP on PDGF-beta receptor. We conclude that although cyclic AMP attenuates the PDGF-Rbeta mediated intracellular transduction pathway, an intact actin filament may be required for the PDGF-BB-induced DNA synthesis in VSMCs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928958      PMCID: PMC1572234          DOI: 10.1038/sj.bjp.0703480

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

Review 2.  Bidirectional signaling between the cytoskeleton and integrins.

Authors:  S M Schoenwaelder; K Burridge
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

Review 3.  Functional design in the actin cytoskeleton.

Authors:  J V Small; K Rottner; I Kaverina
Journal:  Curr Opin Cell Biol       Date:  1999-02       Impact factor: 8.382

4.  Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells.

Authors:  E Giasson; M J Servant; S Meloche
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

5.  Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells.

Authors:  A Simm; V Hoppe; D Karbach; M Leicht; A Fenn; J Hoppe
Journal:  Exp Cell Res       Date:  1998-11-01       Impact factor: 3.905

6.  Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension.

Authors:  S Huang; C S Chen; D E Ingber
Journal:  Mol Biol Cell       Date:  1998-11       Impact factor: 4.138

7.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

8.  Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.

Authors:  G L'Allemain; J N Lavoie; N Rivard; V Baldin; J Pouyssegur
Journal:  Oncogene       Date:  1997-04-24       Impact factor: 9.867

9.  Increasing cAMP antagonizes hypertrophic response to angiotensin II without affecting Ras and MAP kinase activation in vascular smooth muscle cells.

Authors:  T Takahashi; Y Kawahara; M Okuda; M Yokoyama
Journal:  FEBS Lett       Date:  1996-11-11       Impact factor: 4.124

10.  Forskolin inhibits cyclin D1 expression in cultured airway smooth-muscle cells.

Authors:  N L Musa; M Ramakrishnan; J Li; S Kartha; P Liu; R G Pestell; M B Hershenson
Journal:  Am J Respir Cell Mol Biol       Date:  1999-02       Impact factor: 6.914

View more
  1 in total

1.  Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors.

Authors:  A H Eid; M A Chotani; S Mitra; T J Miller; N A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.